UniCredit Aktienanleihe OMV 31.12.../ DE000HD1QP89 /
15/11/2024 19:36:54 | Diferencia-0.100 | Bid21:59:24 | Ask21:59:24 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
100.720EUR | -0.10% | 99.650 Volumen de oferta: 60,000 |
102.220 Tamaño/ Volumen/ Formato de Ask: 60,000 |
OMV AG | 34.2072 EUR | 31/12/2024 | Call |
GlobeNewswire
26/03
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
16/01
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
14/09/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
- Primera página
- Atrás
- 1
- 2
- Siguiente
- Última página